| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| Do | Scandinavian Real Heart AB: Realheart Sets February 2028 Target to Be Ready for First-in-Human Implantation and Provides Development Update | 134 | GlobeNewswire (Europe) | Västerås - Scandinavian Real Heart AB (publ) today announced that the Company's Board of Directors has adopted a new strategic goal: that the Company shall be ready for the first-in-human implantation... ► Artikel lesen | |
| 28.05. | Scandinavian Real Heart AB: Bulletin from the Annual General Meeting of Scandinavian Real Heart AB on May 28, 2026 | 292 | GlobeNewswire (Europe) | On 28 May 2026, Scandinavian Real Heart AB (the "Company") held its Annual General Meeting (AGM) at which the following resolutions were adopted.
Adoption of the income statement and balance sheet... ► Artikel lesen | |
| 28.05. | Scandinavian Real Heart AB: Realheart Granted Patent Approval in Australia | 223 | GlobeNewswire (Europe) | Västerås, Sweden, June 28, 2026 - Scandinavian Real Heart AB (publ) today announced that IP Australia, the Australian intellectual property rights agency, has granted Realheart a patent covering central... ► Artikel lesen | |
| 21.04. | Scandinavian Real Heart data supports total artificial heart system | 1 | MassDevice | ||
| 04.03. | Scandinavian Real Heart AB: Realheart Receives Patent Approval in India | 352 | GlobeNewswire (Europe) | Västerås, Sweden, March 4 2026 - Scandinavian Real Heart AB (publ) announces today that the company has been granted a patent approval in India. The patent covers a control method and system configuration... ► Artikel lesen | |
| 19.02. | Scandinavian Real Heart AB: Year-End Report H2 2025 | 356 | GlobeNewswire (Europe) | Summary of Year-End Report H2 2025
Group Overview2025-07-012024-07-012025-01-012024-01-012025-12-312024-12-312025-12-312024-12-316 mon6 mon12 mon12 monOperating income62 5129 674153 09850 054Earnings... ► Artikel lesen | |
| 11.02. | Scandinavian Real Heart AB: Realheart Receives Patent Approval in Europe | 318 | GlobeNewswire (Europe) | Västerås, Sweden, February 11, 2026 - Scandinavian Real Heart AB (publ) announces today that the company has been granted patent approval by the European Patent Office (EPO). The patent concerns both... ► Artikel lesen | |
| SCANDINAVIAN REAL HEART Aktie jetzt für 0€ handeln | |||||
| 28.01. | Scandinavian Real Heart AB: Scandinavian Real Heart AB announces outcome of the Company's rights issue | 376 | GlobeNewswire (Europe) | NOT FOR PUBLICATION, DISTRIBUTION OR RELEASE, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES, CANADA, JAPAN, SOUTH AFRICA OR AUSTRALIA OR ANY OTHER JURISDICTION IN WHICH SUCH RELEASE OR DISTRIBUTION... ► Artikel lesen | |
| 07.01. | XFRA CAPITAL ADJUSTMENT INFORMATION - 07.01.2026 | 840 | Xetra Newsboard | Das Instrument SFTU US83404D1090 SOFTBANK GR.UNS.ADR1/2/ON EQUITY wird cum Kapitalmassnahme gehandelt am 07.01.2026 und ex Kapitalmassnahme am 08.01.2026 The instrument SFTU US83404D1090 SOFTBANK GR.UNS.ADR1/2/ON... ► Artikel lesen | |
| 16.12.25 | Scandinavian Real Heart AB: Realheart resolves on a rights issue of SEK 70 million | 371 | GlobeNewswire (Europe) | NOT FOR PUBLICATION, DISTRIBUTION OR RELEASE, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES, CANADA, JAPAN, SOUTH AFRICA OR AUSTRALIA OR ANY OTHER JURISDICTION IN WHICH SUCH RELEASE OR DISTRIBUTION... ► Artikel lesen | |
| 16.12.25 | Scandinavian Real Heart AB: Bulletin from the Extraordinary General Meeting in Scandinavian Real Heart AB (publ) on 16 December 2025 | 251 | GlobeNewswire (Europe) | Scandinavian Real Heart AB (publ) held an Extraordinary General Meeting on December 16, 2025. All decisions were made in accordance with the proposals set out in the notice.
Resolutions at the General... ► Artikel lesen | |
| 27.11.25 | XFRA CAPITAL ADJUSTMENT INFORMATION - 27.11.2025 | 1.305 | Xetra Newsboard | Das Instrument B0M SGXE21011833 ALPINA HOLDINGS EQUITY wird cum Kapitalmassnahme gehandelt am 27.11.2025 und ex Kapitalmassnahme am 28.11.2025 The instrument B0M SGXE21011833 ALPINA HOLDINGS EQUITY... ► Artikel lesen | |
| 05.11.25 | Scandinavian Real Heart AB: Realheart Receives Patent Approvals in Key Asian Markets | 363 | GlobeNewswire (Europe) | Västerås, Sweden, November 5, 2025 - Scandinavian Real Heart AB (publ) announces today that the company has been granted patent approvals in China and Japan. The patents concern both the core technology... ► Artikel lesen | |
| 26.09.25 | Scandinavian Real Heart AB: Realheart Receives Patent Approval in Japan | 485 | GlobeNewswire (Europe) | Västerås, Sweden, September 26, 2025 - Scandinavian Real Heart AB (publ) announces today that the company has been granted patent approval by the Japan Patent Office (JPO) concerning the automatic control... ► Artikel lesen | |
| 17.09.25 | Scandinavian Real Heart AB: Realheart Publishes Positive Blood Flow Data Using a Groundbreaking 4D Medical Imaging Method | 478 | GlobeNewswire (Europe) | Västerås, Sweden, September 17, 2025 - Scandinavian Real Heart AB (publ) announces today that the company and its academic partner at Linköping University has published results from a scientific study... ► Artikel lesen | |
| 28.08.25 | Scandinavian Real Heart AB: Interim Report April - June 2025 | 404 | GlobeNewswire (Europe) | Summary of Interim Report April - June 2025Group Overview2025-04-012024-04-012025-01-012024-01-012024-01-012025-06-302024-06-302025-06-302024-06-302024-12-313 mon3 mon6 mon6 mon12 monOperating income20... ► Artikel lesen |
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| UNITEDHEALTH | 341,80 | -0,12 % | UnitedHealth: Strategischer Durchbruch in der Gesundheitsbranche | ||
| INMODE | 12,765 | -1,39 % | InMode Ltd.: InMode Reports Second Quarter 2026 Financial Results: Quarterly GAAP Revenues of $95.6 Million, Consistent with the Second Quarter of 2025 | YOKNEAM, Israel, Aug. 5, 2026 /PRNewswire/ -- InMode Ltd. (Nasdaq: INMD) ("InMode"), a leading global provider of innovative medical technologies, today announced... ► Artikel lesen | |
| SIENNA SENIOR LIVING | 13,200 | -2,94 % | Sienna Senior Living: Sienna Announces August Dividend | MARKHAM, Ontario, Aug. 14, 2026 (GLOBE NEWSWIRE) -- Sienna Senior Living Inc. ("Sienna" or the "Company") (TSX: SIA) today announced a dividend of $0.078 per common share of the Company (each, a "Common... ► Artikel lesen | |
| LIFECLEAN INTERNATIONAL | 0,002 | 0,00 % | LifeClean International AB (publ) receives observation status | Today, June 15, 2026, LifeClean International AB (publ) (the "Company") issued a press release with information that the Company's board of directors had resolved to apply for delisting of the Company's... ► Artikel lesen | |
| ALIGNMENT HEALTHCARE | 13,430 | 0,00 % | Alignment Healthcare files motion to dismiss whistleblower lawsuit | ||
| BRIGHTSPRING HEALTH SERVICES | 59,49 | 0,00 % | BrightSpring Health Services, Inc. Reports Second Quarter 2026 Financial Results and Increases Full Year 2026 Guidance | LOUISVILLE, Ky., July 31, 2026 (GLOBE NEWSWIRE) -- BrightSpring Health Services, Inc. ("BrightSpring" or the "Company") (NASDAQ: BTSG), a leading provider of home and community-based health services... ► Artikel lesen | |
| HEARTFLOW | 50,22 | +0,04 % | Biotech Stocks At 52-Week Highs - Vogenx, Pharvaris, Solventum, Inhibikase Therapeutics, HeartFlow | WASHINGTON (dpa-AFX) - The following biotech stocks reached a 52-week high on August 24, 2026, driven by positive results from clinical trials or an upcoming conference participation. Vogenx... ► Artikel lesen | |
| AVEANNA HEALTHCARE | 13,705 | +0,04 % | Aveanna Healthcare (AVAH) Just Ended A Four-Year Rate Fight | ||
| BETA BIONICS | 19,730 | 0,00 % | Innovative Insulin Pumps Drive Optimism for Tandem, Beta Bionics | ||
| PROGYNY | 25,450 | 0,00 % | Progyny vor dem Boom?: Wells Fargo sieht bei dieser "Kinderwunsch-Aktie" 42 % Kurspotenzial | © Foto: SOPA Images - Sipa USAWells Fargo traut Progyny 42 Prozent Kurspotenzial zu. Das Geschäft mit Kinderwunsch-Leistungen könnte jetzt zum großen Wachstumstreiber werden Enthaltene Werte: US74340E1038Den... ► Artikel lesen | |
| BILLIONTOONE | 96,75 | +0,01 % | BillionToOne Appoints Ethan Dmitrovsky, MD, as Chief Medical Officer, Oncology, to Lead Medical Strategy for Northstar | Renowned physician-scientist, former Director of Frederick National Laboratory, and one of the nation's most accomplished leaders in oncology joins BillionToOne... ► Artikel lesen | |
| SIEMENS HEALTHINEERS | 40,030 | -0,89 % | DEUTSCHE BANK RESEARCH stuft Siemens Healthineers auf 'Hold' | FRANKFURT (dpa-AFX Analyser) - Deutsche Bank Research hat das Kursziel für Siemens Healthineers von 38 auf 39 Euro angehoben und die Einstufung auf "Hold" belassen. Nach einem gemischten Quartal des... ► Artikel lesen | |
| GENEDX | 85,30 | +0,13 % | GeneDx study shows rapid genome sequencing benefits beyond ICUs | ||
| LIFESTANCE HEALTH GROUP | 12,150 | -0,08 % | LifeStance Health Group, Inc.: LifeStance Reports Strong Second Quarter 2026 Financial Results and Raises Full Year Outlook | SCOTTSDALE, Ariz., Aug. 06, 2026 (GLOBE NEWSWIRE) -- LifeStance Health Group, Inc. (Nasdaq: LFST), one of the nation's largest providers of outpatient mental healthcare, today announced financial... ► Artikel lesen | |
| SANARA MEDTECH | 34,350 | 0,00 % | Sanara MedTech Inc. Reports Second Quarter 2026 Financial Results (Unaudited) | FORT WORTH, TX, Aug. 11, 2026 (GLOBE NEWSWIRE) -- Sanara MedTech Inc. ("Sanara," "Sanara MedTech," the "Company," "we," "our" or "us") (Nasdaq: SMTI), a medical technology company focused on developing... ► Artikel lesen |